Leukocyte Typing II

I. Introduction.- 1. B Cell/Leukemia Panel Workshop: Summary and Comments.- II. Serologic Specificity of B Cell/Leukemia Monoclonal Antibodies.- 2. Analysis of the B Cell/Leukemia Workshop Monoclonal Antibodies Using an Immunoenzymatic Staining Assay and a Radioimmunoassay on Cells.- 3. Analysis of Ten B Lymphocyte-Specific Workshop Monoclonal Antibodies.- 4. Screening of Workshop “B” Series Antibodies by Radioimmunobinding to Human Leukocyte Cell Lines and to Cells from Human Lymphoid Tumors.- 5. Expression of Lymphocyte Differentiation Antigens in Immunodeficiency Diseases.- 6. Use of Two Monoclonal Anti-Human B Cell Antibodies in the Study of Early B Cell Differentiation.- 7. Characterization of a Human B Lymphocyte-Specific Antigen Defined by Monoclonal Antibodies HD6 and HD39.- 8. Six Distinct Antigen Systems of Human B Cells as Defined by Monoclonal Antibodies.- 9. B-C1, B-C2, B-C3: Monoclonal Antibodies against B Cell Differentiation Antigens.- 10. Human B Cells: Is FMC7 a Marker for Relatively Mature B Cells or Does It Define a Population Equivalent to the LyB5-Negative Mouse B Cells?.- 11. Spontaneous Mouse Erythrocyte Rosette Formation (M-RFC) with Human B Lymphocytes: Diagnostic Value in B-Lymphoproliferative Diseases and Lack of Relationship to B Cell Protocol Monoclonal Antibodies.- III. Biochemical Analysis of Antigens Defined by the Workshop B Cell/Leukemia Panel.- 12. Human B Cell Surface Molecules Defined by an International Workshop Panel of Monoclonal Antibodies.- 13. Structural Analysis of Cell Surface Molecules Recognized by Leukemic Cell/B Cell Panel Antibodies.- 14. Biochemical Analysis of Antigens Recognized by Workshop B Series Antibodies, Using “Western Blotting”.- 15. Human B Cell Antigens Detected by the Workshop Antibodies: AComparison of Serological and Immunochemical Patterns.- 16. Further Evidence that the Human Differentiation Antigen p24 Possesses Activity Associated with Protein Kinase.- 17. Clustering of Anti-Leukemia and Anti-B Cell Monoclonal Antibodies.- 18. A Structurally Novel Human B Cell Surface Molecule.- 19. Human Neutrophils Synthesize Different Forms of the Common Acute Lymphoblastic Leukemia Antigen.- IV. Immunohistochemical Analysis of B Cell/Leukemia Panel Monoclonal Antibodies.- 20. Immunohistochemical Analysis of Monoclonal Anti-B Cell Antibodies.- 21. Analysis of B and L Workshop Antibodies on Sections of Normal and Neoplastic Lymphoid Tissue and Cell Lines.- 22. Immunohistological Analysis of Tissue Specificity of the Fifty-two Workshop Anti-B Lymphocyte Monoclonal Antibodies.- 23. Reactivity of Monoclonal Antibodies of the B and L Series with Follicular Dendritic Cells in Tissue Sections and with Lymphoblastoid Cell Lines.- 24. The Staining of a Panel of Routine Diagnostic Tissue Biopsies with the Workshop “L” Series Antibodies.- 25. Immunohistochemical Reactivity of Anti-B Cell Monoclonal Antibodies in Thymus, Lymph Node, and Normal Skin.- 26. Report to Second International Workshop on Human Leukocyte Differentiation Markers: Boston, 1984. Tissue Localization of B Cell and Leukemic Reagents (Special Studies).- V. Expression of B Cell/Leukemia Panel on Leukemias and Lymphomas.- 27. Quantitative Phenotypes of B Chronic Lymphocytic Leukemia B Cells Established with Monoclonal Antibodies from the B Cell Protocol.- 28. Analysis of Workshop “L” Series Antibodies: Radioimmunobinding and Biochemical Studies.- 29. Subclassification of Leukemia Using Monoclonal Antibodies.- 30. Immunological Classification of “Unclassifiable” Acute Leukemia.- 31. AgePredilection of Distinct Phenotypically Defined Subgroups of Non-T Cell ALL: Studies Using B Cell-Restricted or -Associated Monoclonal Antibodies in 359 Patients.- 32. Heterogeneity of B-CLL Cells Defined by Monoclonal Antibodies.- 33. HD37 Monoclonal Antibody: A Useful Reagent for Further Characterization of “Non-T, Non-B” Lymphoid Malignancies.- 34. Characterization of Burkitt’s Lymphoma Cell Lines with Monoclonal Antibodies Using an ELISA Technique.- VI. Functional Significance of Human B Cell/Leukemia Antigens.- 35. Human B Cell Populations Defined by the B1 and B2 Antigens.- 36. Phenotypic Changes Occurring during in vitro Activation of Human Splenic B Lymphocytes.- 37. Antigenic Changes of the B Cell Panel of the Second International Workshop on Human Leukocyte Differentiation Antigens with in vitro Activation.- 38. Activation of Human B Cells with Monoclonal Antibody to the Bp32 Cell Surface Polypeptide.- 39. B Lymphocyte Surface Antigens Involved in the Regulation of Immunoglobulin Secretion.- 40. Inhibition of Immunoglobulin Secretion, But Not Immunoglobulin Synthesis, by a Monoclonal Antibody.- 41. Monoclonal Antibody AB1 Identifies a Human B Cell Activation Antigen and Inhibits Growth Factor-Dependent Human B Cell Proliferation.- 42. Detection and Functional Studies of IL-2 Receptors on Activated Human B Cells.- 43. The C3d Receptor Identified by the HB-5 Monoclonal Antibody: Expression and Role as a Receptor for Epstein-Barr Virus.- 44. The B Cell-Restricted Glycoprotein (B2) Is the Receptor for Epstein-Barr Virus.- 45. Monoclonal Antibody-Defined Cell Surface Molecules Regulate Lymphocyte Activation.- 46. TPA-Induced Modulation of B Cell Differentiation Antigens Defined by Monoclonal Antibodies (HD6, HD28, HD37, HD39).- 47. Functional Studies of p24:Platelet Aggregation Inhibition by Fab Monomers of BA-2.